The A3 Collaborative, a yearlong value-based care initiative, has shared initial results and the numbers are impressive.
A 40% reduction in both 30-day hospital readmissions and one-year mortality, and more than $1 million in savings, are just some of the outcomes detailed in interviews with Pharmacy Practice News.
Coupled with big gains in hepatitis C screening and a large uptick in cures as a result of more consistent HCV treatment, the results underscore the value of